Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > PR - taking contract sales force inhouse

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Feb 15, 2022 8:26am

157 Views

Post# 34429182

RE:RE:PR - taking contract sales force inhouse

So far they contracted the sale force the advantages are less hands on and headaches the disadvantages are the legal obligations based on the contract and less direct influence on the performance as for cost it might make no difference at all as I am sure there were some administrative expenses priced in in the contract so the middle man is cut off now.